Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Respiratory/Pulmonary Market Research

Global Cystic Fibrosis (CF) Lung Disease Market (2024 Edition): Analysis By Drug Type (CFTR Modulators, Bronchodilators, Mucolytics, Anti-infectives), Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019

Best Price Guarantee Length Publisher Published Date SKU
from $2,450 250 Pages Azoth Analytics January, 2024 AZAN18445625
Best Price Guarantee
Price from $2,450
Length 250 Pages
Publisher Azoth Analytics
Published Date January, 2024
SKU AZAN18445625

Global Cystic Fibrosis (CF) Lung Disease Market (2024 Edition): Analysis By Drug Type (CFTR Modulators, Bronchodilators, Mucolytics, Anti-infectives), Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)


Executive Summary

Azoth Analytics has released a research report titled “Cystic Fibrosis Lung Disease Market (2024 Edition)” which provides a complete analysis of the global Cystic Fibrosis Lung Disease industry in terms of market segmentation by Drug Type (CFTR Modulators, Bronchodilators, Mucolytics, Anti-infectives) and By Route of Administration (Oral, Inhalation, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel) for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Australia, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research also assesses market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution. During the forecast period, 2024-2029, the Global Cystic Fibrosis Lung Disease market is expected to grow at a CAGR of 25.7%. The Global Cystic Fibrosis Lung Disease Market is expected to generate USD 46.87 Billion by the end of 2029, up from USD 10.75 Billion in 2022.

The cystic fibrosis lung disease market is propelled by continuous advancements in therapeutic interventions. Pharmaceutical companies are investing heavily in research and development to bring innovative treatments to the forefront. Moreover, the emergence of novel drugs and therapies, such as gene therapies and CFTR modulators, has significantly improved the treatment landscape for cystic fibrosis patients. These advancements not only enhance patient outcomes but also contribute to the overall growth of the market.

Additionally, the rising awareness of cystic fibrosis among healthcare professionals and patients is a significant driver for market growth. Improved diagnostic capabilities and increased disease education efforts contribute to early detection and intervention which is contributing to the market growth.

Scope of the Report
  • The report analyses the Cystic Fibrosis Lung Disease Market by Value (USD Billion).
  • The report presents the analysis of the Cystic Fibrosis Lung Disease Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
  • The report analyses the Cystic Fibrosis Lung Disease Market by Drug Type (CFTR Modulators, Bronchodilators, Mucolytics).
  • The report analyses the Cystic Fibrosis Lung Disease Market By Route of Administration (Oral, Inhalation, Intravenous)
  • The report analyses the Cystic Fibrosis Lung Disease Market By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, Drug Type, Route of Administration and Distribution Channels.
  • Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
  • The report also analyses the pipeline framework of the Dugs for the Cystic Fibrosis Lung Disease
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Vertex Pharmaceuticals, Gsk plc, Novartis AG, Roche Holding AG, Bayer AG, Gilead Sciences, Chiesi Farmaceutici S.p.A., Enterprise Therapeutics, and Laurent Pharma.


1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
3. Global Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)
3.1 Cystic Fibrosis Lung Disease: Fact Sheet
3.2 Cystic fibrosis therapies targeting Lung symptoms in Pipeline
Table A1: Cystic fibrosis Therapeutics in pipeline
3.3 Cystic fibrosis small molecule therapies and their targeted mutations
Table A2: Cystic fibrosis Small molecule therapies and their targeted mutations
3.4 Non-viral vectors commonly used for gene and drug delivery in CF patients
Table A3: Non-viral vectors commonly used for gene and drug delivery in CF patients
3.5 Global Cystic Fibrosis Lung Disease Market : Dashboard
3.6 Global Cystic Fibrosis Lung Disease Market: Market Value Assessment, 2019H-2029F (USD Billion)
Table 1: Global Cystic Fibrosis Lung Disease Market Size, By Value, 2019-2022 (USD Billion)
Table 2: Global Cystic Fibrosis Lung Disease Market Size, By Value, 2023-2029 (USD Billion)
Table 3: Global Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
3.7 Impact of COVID-19 on Global Cystic Fibrosis Lung Disease Market
3.8 Global Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
3.8.1 Global Cystic Fibrosis Lung Disease Market, By Drug Type Type Overview
3.8.2 Global Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
Table 4: Global Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
Table 5: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By CFTR modulators, 2019-2029 (USD Billion)
3.8.3 Global Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
Table 6: Global Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
Table 7: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Bronchodilators, 2019-2029 (USD Billion)
3.8.4 Global Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
Table 8: Global Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
Table 9: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Mucolytics, 2019-2029 (USD Billion)
3.8.5 Global Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
Table 10: Global Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
Table 11: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Anti infectives, 2019-2029 (USD Billion)
3.9 Global Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
3.9.1 Global Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
3.9.2 Global Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Table 12: Global Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Table 13: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Oral, 2019-2029 (USD Billion)
3.9.3 Global Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
Table 14: Global Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
Table 15: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Inhalation, 2019-2029 (USD Billion)
3.9.4 Global Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
Table 16: Global Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
Table 17: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Intravenous, 2019-2029 (USD Billion)
3.10 Global Cystic Fibrosis Lung Disease Market Segmentation: By Distribution Channel
3.10.1 Global Cystic Fibrosis Lung Disease Market, By Distribution Channel Overview
3.10.2 Global Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies By Value, 2019H-2029F (USD Billion & CAGR)
Table 18: Global Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Table 19: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Hospital Pharmacies, 2019-2029 (USD Billion)
3.10.3 Global Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Table 20: Global Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Table 21: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Retail Pharmacies, 2019-2029 (USD Billion)
3.10.4 Global Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
Table 22: Global Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
Table 23: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Online Channel, 2019-2029 (USD Billion)
4. Global Cystic Fibrosis Lung Disease Market, Regional Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)
5.1 Americas Cystic Fibrosis Lung Disease Market: Snapshot
5.2 Americas Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Billion & CAGR)
Table 24: Americas Cystic Fibrosis Lung Disease Market Size, By Value, 2019H-2029F (USD Billion)
Table 25: Americas Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
5.3 Americas Cystic Fibrosis Lung Disease Market: Key Factors
5.4 Americas Cystic Fibrosis Lung Disease Market : Segment Analysis
5.5 Americas Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
5.5.1 Americas Cystic Fibrosis Lung Disease Market, By Drug Type Overview
5.5.2 Americas Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
Table 26: Americas Cystic Fibrosis Lung Disease Market, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.3 Americas Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
Table 27: Americas Cystic Fibrosis Lung Disease Market, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.4 Americas Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
Table 28: Americas Cystic Fibrosis Lung Disease Market, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.5 Americas Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
Table 29: Americas Cystic Fibrosis Lung Disease Market, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
5.6 Americas Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
5.6.1 Americas Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
5.6.2 Americas Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Table 30: Americas Cystic Fibrosis Lung Disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
5.6.3 Americas Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
Table 31: Americas Cystic Fibrosis Lung Disease Market, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
5.6.4 Americas Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
Table 32: Americas Cystic Fibrosis Lung Disease Market, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
5.7 Americas Cystic Fibrosis Lung Disease Market Segmentation: By Distribution Channel
5.7.1 Americas Cystic Fibrosis Lung Disease Market, By Distribution Channel Overview
5.7.2 Americas Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Table 33: Americas Cystic Fibrosis Lung Disease Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
5.7.3 Americas Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Table 34: Americas Cystic Fibrosis Lung Disease Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
5.7.4 Americas Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
Table 35: Americas Cystic Fibrosis Lung Disease Market, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
5.8 Americas Cystic Fibrosis Lung Disease Market Segmentation : By Country
5.8.1 United States Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
Table 36: United States Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Table 37: United States Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
5.8.1.1 United States Cystic Fibrosis Lung Disease Market, By Drug Type
Table 38: United States Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Table A4: United States Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A5: United States Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
5.8.1.2 United States Cystic Fibrosis Lung Disease Market, By Route of Administration
Table 39: United States Cystic Fibrosis Lung Disease Market Share, By Route of Administration, By Value, 2022 (%)
Table A6: United States Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A7: United States Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
5.8.1.3 United States Cystic Fibrosis Lung Disease Market, By Distribution Channel
Table 40: United States Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Table A8: United States Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A9: United States Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
5.8.2 Canada Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
Table 41: Canada Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Table 42: Canada Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
5.8.2.1 Canada Cystic Fibrosis Lung Disease Market, By Drug Type
Table 43: Canada Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Table A10: Canada Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A11: Canada Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
5.8.2.2 Canada Cystic Fibrosis Lung Disease Market, By Route of Administration
Table 44: Canada Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Table A12: Canada Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A13: Canada Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
5.8.2.3 Canada Cystic Fibrosis Lung Disease Market, By Distribution Channel
Table 45: Canada Cystic Fibrosis Lung Disease Market Share, Distribution Channel, 2022 (%)
Table A14: Canada Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A15: Canada Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
5.8.3 Rest of Americas Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
FTable 46: Rest of Americas Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Table 47: Rest of Americas Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
5.8.3.1 Rest of Americas Cystic Fibrosis Lung Disease Market, By Drug Type
Table 48: Rest of Americas Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Table A16: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A17: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
5.8.3.2 Rest of Americas Cystic Fibrosis Lung Disease Market, By Route of Administration
Table 49: Rest of Americas Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Table A18: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A19: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
5.8.3.3 Rest of Americas Cystic Fibrosis Lung Disease Market, By Distribution Channel
Table 50: Rest of Americas Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Table A20: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A21: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
6. Europe Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)
6.1 Europe Cystic Fibrosis Lung Disease Market: Snapshot
6.2 Europe Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Billion & CAGR)
Table 51: Europe Cystic Fibrosis Lung Disease Market Size, By Value, 2019H-2029F (USD Billion)
Table 52: Europe Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
6.3 Europe Cystic Fibrosis Lung Disease Market: Key Factors
6.4 Europe Cystic Fibrosis Lung Disease Market: Segment Analysis
6.5 Europe Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
6.5.1 Europe Cystic Fibrosis Lung Disease Market, By Drug Type Overview
6.5.2 Europe Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
Table 53: Europe Cystic Fibrosis Lung Disease Market, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.3 Europe Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
Table 54: Europe Cystic Fibrosis Lung Disease Market, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.4 Europe Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
Table 55: Europe Cystic Fibrosis Lung Disease Market, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.5 Europe Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
Table 56: Europe Cystic Fibrosis Lung Disease Market, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
6.6 Europe Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
6.6.1 Europe Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
6.6.2 Europe Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Table 57: Europe Cystic Fibrosis Lung Disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
6.6.3 Europe Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
Table 58: Europe Cystic Fibrosis Lung Disease Market, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
6.6.4 Europe Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
Table 59: Europe Cystic Fibrosis Lung Disease Market, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
6.7 Europe Cystic Fibrosis Lung Disease Market Segmentation: By Distribution Channel
6.7.1 Europe Cystic Fibrosis Lung Disease Market, By Distribution Channel Overview
6.7.2 Europe Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Table 60: Europe Cystic Fibrosis Lung Disease Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
6.7.3 Europe Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Table 61: Europe Cystic Fibrosis Lung Disease Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
6.7.4 Europe Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
Table 62: Europe Cystic Fibrosis Lung Disease Market, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
6.8 Europe Cystic Fibrosis Lung Disease Market Segmentation : By Country
6.8.1 Germany Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
Table 63: Germany Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Table 64: Germany Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
6.8.1.1 Germany Cystic Fibrosis Lung Disease Market, By Drug Type
Table 65: Germany Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Table A22: Germany Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A23: Germany Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
6.8.1.2 Germany Cystic Fibrosis Lung Disease Market, By Route of Administration
Table 66: Germany Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Table A24: Germany Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A25: Germany Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
6.8.1.3 Germany Cystic Fibrosis Lung Disease Market, By Distribution Channel
Table 67: Germany Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Table A26: Germany Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A27: Germany Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
6.8.2 United Kingdom Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
Table 68: United Kingdom Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Table 69: United Kingdom Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
6.8.2.1 United Kingdom Cystic Fibrosis Lung Disease Market, By Drug Type
Table 70: United Kingdom Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Table A28: United Kingdom Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A29: United Kingdom Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
6.8.2.2 United Kingdom Cystic Fibrosis Lung Disease Market, By Route of Administration
Table 71: United Kingdom Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Table A30: United Kingdom Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A31: United Kingdom Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
6.8.2.3 United Kingdom Cystic Fibrosis Lung Disease Market, By Distribution Channel
Table 72: United Kingdom Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Table A32: United Kingdom Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A33: United Kingdom Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
6.8.3 France Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
Table 73: France Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Table 74: France Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
6.8.3.1 France Cystic Fibrosis Lung Disease Market, By Drug Type
Table 75: France Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Table A34: France Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A35: France Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
6.8.3.2 France Cystic Fibrosis Lung Disease Market, By Route of Administration
Table 76: France Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Table A36: France Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A37: France Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
6.8.3.3 France Cystic Fibrosis Lung Disease Market, By Distribution Channel
Table 77: France Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Table A38: France Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A39: France Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
6.8.4 Italy Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
Table 78: Italy Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Table 79: Italy Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
6.8.4.1 Italy Cystic Fibrosis Lung Disease Market, By Drug Type
Table 80: Italy Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Table A40: Italy Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A41: Italy Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
6.8.4.2 Italy Cystic Fibrosis Lung Disease Market, By Route of Administration
Table 81: Italy Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Table A42: Italy Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A43: Italy Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
6.8.4.3 Italy Cystic Fibrosis Lung Disease Market, By Distribution Channel
Table 82: Italy Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Table A44: Italy Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A45: Italy Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
6.8.5 Spain Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
Table 83: Spain Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Table 84: Spain Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
6.8.5.1 Spain Cystic Fibrosis Lung Disease Market, By Drug Type
Table 85: Spain Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Table A46: Spain Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A47: Spain Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
6.8.5.2 Spain Cystic Fibrosis Lung Disease Market, By Route of Administration
Table 86: Spain Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Table A48: Spain Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A49: Spain Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
6.8.5.3 Spain Cystic Fibrosis Lung Disease Market, By Distribution Channel
Table 87: Spain Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Table A50: Spain Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A51: Spain Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
6.8.6 Rest of Europe Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
Table 88: Rest of Europe Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Table 89: Rest of Europe Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
6.8.6.1 Rest of Europe Cystic Fibrosis Lung Disease Market, By Drug Type
Table 90: Rest of Europe Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Table A52: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A53: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
6.8.6.2 Rest of Europe Cystic Fibrosis Lung Disease Market, By Route of Administration
Table 91: Rest of Europe Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Table A54: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A55: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
6.8.6.3 Rest of Europe Cystic Fibrosis Lung Disease Market, By Distribution Channel
Table 92: Rest of Europe Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Table A56: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A57: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
7. Asia-Pacific Cystic Fibrosis Lung Disease Market: Historic and Forecast
7.1 Asia-Pacific Cystic Fibrosis Lung Disease Market: Snapshot
7.2 Asia-Pacific Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Billion & CAGR)
Table 93: Asia Pacific Cystic Fibrosis Lung Disease Market Size, By Value, 2019H-2029F (USD Billion)
Table 94: Asia Pacific Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
7.3 Asia-Pacific Cystic Fibrosis Lung Disease Market: Key Factors
7.4 Asia-Pacific Cystic Fibrosis Lung Disease Market: Segment Analysis
7.5 Asia-Pacific Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
7.5.1 Asia-Pacific Cystic Fibrosis Lung Disease Market, By Drug Type Overview
7.5.2 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
Table 95: Asia Pacific Cystic Fibrosis Lung Disease Market, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.3 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
Table 96: Asia Pacific Cystic Fibrosis Lung Disease Market, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.4 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
Table 97: Asia Pacific Cystic Fibrosis Lung Disease Market, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.5 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
Table 98: Asia Pacific Cystic Fibrosis Lung Disease Market, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
7.6 Asia-Pacific Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
7.6.1 Asia-Pacific Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
7.6.2 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Table 99: Asia Pacific Cystic Fibrosis Lung Disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
7.6.3 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
Table 100: Asia Pacific Cystic Fibrosis Lung Disease Market, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
7.6.4 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
Table 101: Asia Pacific Cystic Fibrosis Lung Disease Market, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
7.7 Asia-Pacific Cystic Fibrosis Lung Disease Market Segmentation : By Distribution Channel
7.7.1 Asia-Pacific Cystic Fibrosis Lung Disease Market, By Distribution Channel Overview
7.7.2 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Table 102: Asia Pacific Cystic Fibrosis Lung Disease Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
7.7.3 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Table 103: Asia Pacific Cystic Fibrosis Lung Disease Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
7.7.4 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
Table 104: Asia Pacific Cystic Fibrosis Lung Disease Market, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
7.8 Asia-Pacific Cystic Fibrosis Lung Disease Market Segmentation : By Country
7.8.1 China Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
Table 105: China Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Table 106: China Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
7.8.1.1 China Cystic Fibrosis Lung Disease Market, By Drug Type
Table 107: China Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Table A58: China Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A59: China Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

$2,450
$2,950

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings